169 results on '"Allione, B"'
Search Results
2. Early consolidation with high-dose therapy and autologous stem cell transplantation is a feasible and effective treatment option in HIV-associated non-Hodgkin lymphoma at high risk
3. A Landmark Analysis of Survival by Response Category in Elderly Patients with Acute Myeloblastic Leukemia
4. TREATMENT OF POST-HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) HAEMORRHAGIC CYSTITIS WITH INTRAVESCICAL HYALURONIC ACID: PH-P340
5. Impact of the type of anthracycline and of stem cell transplantation in younger patients with acute myeloid leukaemia: Long-term follow up of a phase III study
6. Role of allografting in acute lymphoblastic leukaemia: 12 yearsʼ experience: R1520
7. Pre-transplant low-dose ATG is associated with reduced transplant-related mortality and improved clinical outcome in patients receiving allogeneic HSCT from unrelated and partially matched related donors: P502
8. A prospective study on the feasibility of related and unrelated donor search and haematopoietic cell transplantation for adults with acute leukaemia at 31 European transplant centres: 187
9. Long-term follow-up of a comparison of non-myeloablative allografting with autografting for newly diagnosed myeloma: O158
10. Update of the registration study
11. Tandem auto-miniALLO approach for newly diagnosed multiple myeloma: an update of the Italian experience
12. Low-dose TBI-based non-myeloablative allografting in newly diagnosed multiple myeloma
13. High dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for HIV-associated lymphoma in patients on highly active antiretroviral therapy. A multicentre study
14. Acute myeloid leukemia in patients previously diagnosed with breast cancer: Experience of the GIMEMA group
15. A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia
16. Post-Remissional And Pre-Transplant Role Of MRD Detected By WT1 In Acute Myeloid Leukemia: A Retrospective Cohort Study
17. Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia
18. CD34+ Acute Myeloid and Lymphoid Leukemic Blasts Can Be Induced to Differentiate Into Dendritic Cells
19. Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia
20. Acute promyelocytic leukaemia: epidemiology and risk factors. A report of the GIMEMA Italian archive of adult acute leukaemia
21. A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia
22. Different Repo Doses (High vs Standard) for Treatment of Anemia in MDS Patients: A Survey from the Italian MDS Registry
23. MDS-Can-It: A New Validated International ESA-Response Score that Further Refines the Predictive Power of the Nordic Scoring System
24. Effects of Erythropoiesis-Stimulating Agents on Overall Survival of IPSS Low/INT-1 Risk Transfusion Independent Myelodysplastic Syndrome Patients, a FISM Study
25. Minimal residual disease in acute myeloid leukemia detected by Wilms tumor gene 1 expression and multiparameter flow cytometry
26. WT1 Expression in acute myeloid leukaemia:a useful marker for improving therapy response evaluation
27. ALLOGENEIC STEM CELL TRANSPLANTATION (HSCT) FOR ADULTS WITH MYELODYSPLASTIC SYNDROMES (MDS): RELEVANCE OF PRE-TRANSPLANT DISEASE STATUS
28. Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres
29. Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program
30. Allografting in relapsed/refractory Hodgkin's lymphoma, a single-centre experience
31. 166 TARGETED SEQUENCING ANALYSIS OF COMMONLY MUTATED GENES IN CHRONIC MYELOMONOCYTIC LEUKEMIA USING NGS: IMPACT AND CLINICAL IMPLICATIONS
32. 110 BIOSIMILAR EPOETIN ZETA FOR THE TREATMENT OF ANEMIA IN MYELODYSPLASTIC SYNDROMES (MDS)
33. LONG TERM FOLLOW UP OF A COMPARISON OF NONMYELOABLATIVE ALLOGRAFTING WITH AUTOGRAFTING FOR NEWLY DIAGNOSED MULTIPLE MYELOMA
34. Long-term follow-up of a comparison of non-myeloablative allografting with autografting for newly diagnosed myeloma
35. Invasive aspergillosis in allogeneic stem cell recipients: what are we doing? An Italian prospective study
36. INCIDENCE OF INVASIVE ASPERGILLOSIS IN ALLOGENEIC STEM CELL TRANSPLANTATION RECIPIENTS: AN ITALIAN PROSPECTIVE MULTICENTER STUDY
37. INCIDENCE OF HHV-6 AFTER NONMYELOABLATIVE HSCT IN REFRACTORY MALIGNANCIES
38. TANDEM AUTOGRAFTING-NONMYELOABLATIVE ALLOGRAFTING FOR NEWLY DIAGNOSED MULTIPLE MYELOMA: THE GITMO EXPERIENCE
39. Nonmyeloablative allogeneic stem cell transplantation in elderly patients with hematological malignancies: results from the GITMO (Gruppo Italiano Trapianto Midollo Osseo) multicenter prospective clinical trial
40. Nonmyeloablative allografting or autografting for newly diagnosed multiple myeloma
41. A prospective phase II study on tandem autografting - Nonmyeloablative allografting for newly diagnosed multiple myeloma: Final results of a multicenter GITMO (Gruppo Italiano Trapianto Midollo Osseo) protocol
42. A PROSPECTIVE PHASE II STUDY ON TANDEM AUTOGRAFTING-ONMYELOABLATIVE ALLOGRAFTING FOR NEWLY DIAGNOSED MULTIPLE MYELOMA: FINAL RESULTS OF A MULTICENTER GITMO (GRUPPO ITALIANO TRAPIANTO MIDOLLO OSSEO) PROTOCOL
43. Tandem autografting-nonmyeloablative allografting for newly diagnosed multiple myeloma: The GITMO (gruppo italiano trapianto midollo osseo) experience
44. 226 - MDS-Can-It: A New Validated International ESA-Response Score that Further Refines the Predictive Power of the Nordic Scoring System
45. 93 - Effects of Erythropoiesis-Stimulating Agents on Overall Survival of IPSS Low/INT-1 Risk Transfusion Independent Myelodysplastic Syndrome Patients, a FISM Study
46. 91 - Different Repo Doses (High vs Standard) for Treatment of Anemia in MDS Patients: A Survey from the Italian MDS Registry
47. LIMITED GRAFT-VERSUS MYELOMA EFFECT AFTER LOW-DOSE TBI BASED NON-MYELOABLATIVE ALLOGRAFTING EMPLOYED AS SALVAGE TREATMENT COMPARED TO FIRST LINE TREATMENT
48. Pre-autologous stem cell transplantation (ASCT) treatment with rituximab does not impair stem cell harvest and engraftment in untreated patients with diffuse large B-cell lymphoma (B-DLCL) at poor prognosis
49. TANDEM AUTO-MINI ALLO APPROACH FOR NEWLY DIAGONSED MULTIPLE MYELOMA: AN UPDATE OF THE ITALIAN EXPERIENCE
50. INCIDENCE OF INVASIVE ASPERGILLOSIS IN ALLOGENEIC STEM CELL TRANSPLANTATION PATIENTS: AN ITALIAN PROSPECTIC MULTICENTRE STUDY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.